<DOC>
	<DOC>NCT02934802</DOC>
	<brief_summary>This post-market clinical follow-up study intends to investigate the survival rate at 5 years of the e.motion® PS Pro System.</brief_summary>
	<brief_title>Non-Interventional Consecutive and Prospective Study of e.Motion® PS Pro Prosthesis in the Total Knee Artroplasty</brief_title>
	<detailed_description />
	<criteria>Patient having signed informed consent Patients over 18 for which a Total Knee Prosthesis with e.motion® PS Pro was decided Patients willing to participate in a 5 years followup Active or suspected infection Tumor on the concerned knee Patient vulnerable and under legal protection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>